Details for Patent: 7,259,186
✉ Email this page to a colleague
Which drugs does patent 7,259,186 protect, and when does it expire?
Patent 7,259,186 protects TRILIPIX and is included in one NDA.
This patent has nineteen patent family members in eleven countries.
Summary for Patent: 7,259,186
| Title: | Salts of fenofibric acid and pharmaceutical formulations thereof |
| Abstract: | In one aspect, the present invention relates to a formulation in the form of molecular dispersion comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients.In a second aspect, the present invention relates to novel salts of fenofibric acid that are photostable when compared to other salts of fenofibric acid. |
| Inventor(s): | Cink; Russell Drew (Grayslake, IL), Paterson, Jr.; Joseph B. (Vernon Hills, IL), Gao; Yi (Vernon Hills, IL), Zhang; Geoff G. Z. (Libertyville, IL), Long; Michelle A. (Libertyville, IL), Morris; John B. (Grayslake, IL), Rosenberg; Joerg (Ellerstadt, DE) |
| Assignee: | Abbott Laboratories (Abbott Park, IL) |
| Application Number: | 10/880,851 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Formulation; |
Drugs Protected by US Patent 7,259,186
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | TRILIPIX | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 022224-001 | Dec 15, 2008 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Abbvie | TRILIPIX | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 022224-002 | Dec 15, 2008 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,259,186
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 359777 | ⤷ Try a Trial | |||
| Australia | 2003290060 | ⤷ Try a Trial | |||
| Australia | 2010249244 | ⤷ Try a Trial | |||
| Canada | 2510261 | ⤷ Try a Trial | |||
| China | 100473378 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
